Use of glucagon-like peptide type 1 receptor agonists in kidney transplant recipients Luis Alberto Vigara; Florentino Villanego; Cristhian Orellana; Myriam Eady; María Gabriela Sánchez; Marta Alonso; María Belén García; José Manuel Amaro; Teresa García; Auxiliadora Mazuecos;

Risk factors for progression in patients with KDOQI stage 3 Chronic Kidney Disease (PROGRESER study) Alberto Martínez-Castelao; José Luis Górriz Teruel; Luis D¿Marco; Enrique Garrigós; Gema Fernández-Fresnedo; Eugenia Espinel Garuz; Secundino Cigarrán Guldris; Jesús Arteaga Coloma; Nicolas Roberto Robles Pérez-Monteoliva; José Rafael Esteban de la Rosa; Luis Javier Nieto Iglesias; Alberto Ortiz Arduán; Juan Francisco Navarro-González;

Association between CYP4A11 and EPHX2 genetic polymorphisms and chronic kidney disease progression in hypertensive patients Miguel A. Suárez-Santisteban; Gracia Santos-Díaz; Vanesa García-Bernalt; Ana M. Pérez-Pico; Esther Mingorance; Raquel Mayordomo; Pedro Dorado;